EBRO
2017
Gastric cancer adjuvant chemoradiation
D2 or not D2?
Operative mortality ≥ 10% in D2 patients
No survival benefit for D2 dissection
But modern Japanese trials consistently show ~ 1%
post-operative mortality for ≥ D2 surgery